Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Amyloid plaques and neurofibrillary tangles are key pathological features of Alzheimer's disease. Alzheimer's disease pathology is also characterized by neuroinflammation and neuronal degeneration, with the proteins associated with inflammatory responses being found in tight association with the plaques. One such protein is the serine protease inhibitor alpha-1-antichymotrypsin (ACT). ACT has been shown to promote Abeta polymerization in vitro and in vivo, and levels of ACT protein in plasma and cerebrospinal fluid from Alzheimer's patients have been found to correlate with progression of dementia. Here we investigated the possible involvement of ACT in tau phosphorylation and tangle formation. As was previously found for Alzheimer's disease, brains from patients with non-Alzheimer's tauopathies exhibited an enhanced expression of ACT, which correlated with the level of tau hyperphosphorylation. Transgenic mice expressing human ACT alone or ACT along with mutant human amyloid precursor protein (APP) showed a significant increase in tau phosphorylation, suggesting that this inflammatory protein can induce tau hyperphosphorylation. The increase in phosphorylation was observed at PHF-1 (P-Ser396/P-Thr404), P-Ser202 and P-Thr231 sites on tau, the P-tau epitopes that are associated with tangles in the patients. This result was further confirmed by the finding that addition of purified ACT induced the same Alzheimer's disease-related tau hyperphosphorylation in cortical neurons cultured in vitro. This correlated with an increase in extracellular signal regulated kinase (ERK) and glycogen synthase kinase-3 activation, indicating their involvement in ACT-induced tau phosphorylation. The ACT-treated neurons showed neurite loss and subsequently underwent apoptosis. Approximately 40-50% of neurons were TUNEL positive by 6 and at 24 h >70% of the neurons showed staining suggesting that ACT was inducing apoptosis in these neurons. These findings indicate that inappropriate inflammatory responses are a potential threat to the brain and that intervention directed at inhibiting the expression or function of ACT could be of therapeutic value in neurodegenerative diseases such as Alzheimer's and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Gomez-Isla et al., 1996; Mann, 1996).”
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“…have shown that nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of Alzheimer’s disease possibly through the suppression of neuroinflammation (McGeer et al., 1990, 1994a; McGeer and Rogers, 1992; Rogers et al., 1993, 1996; Weggen et al., 2001, 2003a, b; Klegeris and McGeer, 2005).”
BackgroundStrittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · cited 2×
“Like ApoE, ACT binds to Ab and promotes its assembly into neurotoxic amyloid filaments (Strittmatter et al., 1993b; Ma et al., 1994, 1996; Sanan et al., 1994; Wisniewski et al., 1994; Lukacs and Christianson, 1996; Webster and Rogers, 1996; Abraham et al., 2000).”
BackgroundResultBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · cited 1×
“…tau promotes its dissociation from microtubules and its polymerization into paired helical filaments (PHFs), resulting in disorganization of the microtubule cytoskeleton and blocking of axonal transport (Bramblett et al., 1993; Busciglio et al., 1995; Terwel et al., 2002; Mandelkow et al., 2003).”
BackgroundMa, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · cited 1×
“Like ApoE, ACT binds to Ab and promotes its assembly into neurotoxic amyloid filaments (Strittmatter et al., 1993b; Ma et al., 1994, 1996; Sanan et al., 1994; Wisniewski et al., 1994; Lukacs and Christianson, 1996; Webster and Rogers, 1996; Abraham et al., 2000).”
BackgroundSelf-citationComplement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802 · cited 2×
“…in affected areas of Alzheimer's disease brain, including complement, IL-1b, TNF-a, ApoE, IL-6 and ACT (Abraham et al., 1988; McGeer et al., 1989; Pasternack et al., 1989; Rogers et al., 1992; Wisniewski and Frangione, 1992; Mrak et al., 1995; Nilsson et al., 1998; Potter et al., 2001).”
BackgroundNoble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 1×
“Furthermore, inhibition of GSK-3 has been shown to be associated with a decrease in tau hyperphosphorylation and neurodegeneration (Lucas et al., 2001; Hernandez et al., 2002; Noble et al., 2005; Engel et al., 2006).”
BackgroundSelf-citationBall, M. J. (1977) · Acta Neuropathologica · doi:10.1007/bf00692056 · Cited by 639 · cited 1×
“Alzheimer's disease is a neurodegenerative disease associated with neuronal loss in hippocampus and cortex (Ball, 1977; Arendt et al., 1985; Bobinski et al., 1998; Busser et al., 1998; Fig.”
BackgroundWilcock, G. K., & Esiri, M. M. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90155-1 · Cited by 608
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · cited 2×
“…tau promotes its dissociation from microtubules and its polymerization into paired helical filaments (PHFs), resulting in disorganization of the microtubule cytoskeleton and blocking of axonal transport (Bramblett et al., 1993; Busciglio et al., 1995; Terwel et al., 2002; Mandelkow et al., 2003).”
BackgroundEctopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543 · cited 1×
“Alzheimer's disease is a neurodegenerative disease associated with neuronal loss in hippocampus and cortex (Ball, 1977; Arendt et al., 1985; Bobinski et al., 1998; Busser et al., 1998; Fig.”
BackgroundThe microtubule binding domain of tau protein
Lee, G., Neve, R. L., & Kosik, K. S. (1989) · Neuron · doi:10.1016/0896-6273(89)90050-0 · Cited by 500 · cited 2×
“NFTs are mainly comprised of hyperphosphorylated forms of the microtubule binding protein tau (Delacourte and Defossez, 1986; Kosik et al., 1986, 1988; Lee et al., 1989, 1990; Mandelkow and Mandelkow, 1993; Goedert, 1996).”
BackgroundSanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., & Roses, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117407 · Cited by 404 · cited 1×
“Like ApoE, ACT binds to Ab and promotes its assembly into neurotoxic amyloid filaments (Strittmatter et al., 1993b; Ma et al., 1994, 1996; Sanan et al., 1994; Wisniewski et al., 1994; Lukacs and Christianson, 1996; Webster and Rogers, 1996; Abraham et al., 2000).”
BackgroundActivation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383 · cited 5×
“A number of such inflammatory proteins have been found to be overexpressed in affected areas of Alzheimer’s disease brain, including complement, IL-1b, TNF-a, ApoE, IL-6 and ACT (Abraham et al., 1988; McGeer et al., 1989; Pasternack et al., 1989; Rogers et al., 1992; Wisniewski and Frangione, 1992; Mrak et al., 1995;…”
BackgroundInfluentialA4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
Kamboh, M. I., Sanghera, D. K., Ferrell, R. E., & DeKosky, S. T. (1995) · Nature Genetics · doi:10.1038/ng0895-486 · Cited by 336
Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290 · cited 1×
“IL-1b has been shown to enhance the expression of ACT in human astrocytes and to increase the translation of APP (Das and Potter, 1995; Lieb et al., 1996; Rogers et al., 1999; Kordula et al., 2000; Nilsson et al., 2001b; Kiss et al., 2005).”
BackgroundSelf-citationCho, J., & Johnson, G. V. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02155.x · Cited by 282
Griffin, W. S. T., & Mrak, R. E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.233 · Cited by 248 · cited 1×
“…that activated microglia and astrocytes facilitate neurodegeneration in Alzheimer's disease by not only accelerating amyloid pathology, but also by enhancing the NFT formation (McGeer et al., 1994b; DiPatre and Gelman, 1997; Griffin and Mrak, 2002; Kitazawa et al., 2004; Licastro et al., 2004).”
BackgroundPei, J.-J., Braak, H., An, W.-L., Winblad, B., Cowburn, R. F., Iqbal, K., & Grundke-Iqbal, I. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00488-6 · Cited by 247 · cited 1×
“We first examined the early extracellular signal regulated kinase, ERK, (MAP kinase) since it is one of the kinases known to phosphorylate tau and ERK has been shown to be associated with NFT and senile plaques (Trojanowski et al., 1993; Pei et al., 2002; Zhu et al., 2002).”
BackgroundSheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01063.x · Cited by 181 · cited 1×
“For example, the microglia around the plaques in Alzheimer’s disease brain have been shown to express a high level of the cytokine IL-1b that correlate with the extent of the disease pathology (Griffin et al., 1995; Sheng et al., 1995; Mrak and Griffin, 2001).”
BackgroundDIPATRE, P. L., & GELMAN, B. B. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00004 · Cited by 157
Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease
Terwel, D., Dewachter, I., & Van Leuven, F. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:151 · Cited by 146 · cited 1×
“…tau promotes its dissociation from microtubules and its polymerization into paired helical filaments (PHFs), resulting in disorganization of the microtubule cytoskeleton and blocking of axonal transport (Bramblett et al., 1993; Busciglio et al., 1995; Terwel et al., 2002; Mandelkow et al., 2003).”
BackgroundMucke, L., Yu, G.-Q., McConlogue, L., Rockenstein, E. M., Abraham, C. R., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64839-0 · Cited by 145
Nilsson, L. N. G., Bales, K. R., DiCarlo, G., Gordon, M. N., Morgan, D., Paul, S. M., & Potter, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01444.2001 · Cited by 137 · cited 4×
“The contribution of ACT to both plaque formation and associated cognitive decline has been established in vivo in mice (Mucke et al., 2000; Nilsson et al., 2001a, 2004).”
BackgroundMethodInfluentialSelf-citationAlzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108
Self-citationA DESCRIPTIVE STUDY OF NEURITIC PLAQUES AND NEUROFIBRILLARY TANGLES IN AN AUTOPSY POPULATION
DeWOLFE MILLER, F., HICKS, S. P., D'AMATO, C. J., & LANDIS, J. R. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113897 · Cited by 70
HARIGAYA, Y., SHOJI, M., NAKAMURA, T., MATSUBARA, E., HOSODA, K., & HIRAI, S. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.481 · Cited by 38 · cited 2×
“, 1989) and elevated levels of the protein have been reported in the cerebrospinal fluid and plasma of the patients (Harigaya et al., 1995; Licastro et al., 1995; DeKosky et al., 2003).”
Background
Cited by
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Plasma proteomic signature of age in healthy humans
Tanaka, T., Biancotto, A., Moaddel, R., Moore, A. Z., Gonzalez‐Freire, M., Aon, M. A., Candia, J., Zhang, P., Cheung, F., Fantoni, G., et al. (2018) · Aging Cell · doi:10.1111/acel.12799 · Cited by 562
Cohen, R. M., Rezai-Zadeh, K., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 531
Shen, X.-N., Niu, L.-D., Wang, Y.-J., Cao, X.-P., Liu, Q., Tan, L., Zhang, C., & Yu, J.-T. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319148 · Cited by 388
Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment: A Field in Its Infancy
McGeer, E. G., & McGeer, P. L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1219 · Cited by 346
Metadata
- Authors
- Padmanabhan, J., Levy, M., Dickson, D. W., & Potter, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-29
- Volume
- 129
- Issue
- 11
- Pages
- 3020-3034
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2154471162
- Cited by
- 120
- References
- 30
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.